| ACMG | American College of Medical Genetics |
| BMI | Body Mass Index |
| BRCA1/2 | Breast Cancer Gene 1/2 |
| CA125 | Cancer Antigen 125 |
| CHEK1 | Checkpoint Kinase 1 |
| CNV | Copy Number Variation |
| CT | Computed Tomography |
| DCB | Danish Cancer Biobank |
| DGCD | Danish Gynecological Cancer Database |
| DNA | Deoxyribonucleic Acid |
| FFPE | Formalin-Fixed, Paraffin-Embedded |
| FIGO | International Federation of Gynecology and Obstetrics |
| GIS | Genomic Instability Score |
| HGSC | High-grade Serous Ovarian Cancer |
| HRD | Homologous Recombination Deficiency |
| HRR | Homologous Recombination Repair |
| LOH | Loss of Heterozygosity |
| LST | Large-Scale State Transitions |
| MDPI | Multidisciplinary Digital Publishing Institute |
| MRI | Magnetic Resonance Imaging |
| nLST | Normalized Large-Scale Transitions |
| OCAv3 | Oncomine Comprehensive Assay Version 3 |
| PARP | Poly (ADP-ribose) Polymerase |
| PET-CT | Positron Emission Tomography-Computed Tomography |
| TAI | Telomeric Allelic Imbalance |
| TP53 | Tumor Protein p53 |
| wt | Wild Type |